Treating the neurons and me — my mental states — in a synergistic way proved to speed up and enhance healing. It does for ...

We are pleased to announce that our applications for the higher dose regimen of nusinersen are now under review in the US and Europe,” said Stephanie Fradette, Pharm.D., Head of the Neuromuscular ...

An investigational higher dose of spinal muscular atrophy drug nusinersen gains attention as the FDA and European Medicines Agency (EMA) considerate it as an alternative than the current lower ...

Spinraza remains a big product for Biogen but has seen its sales go into reverse as competition in SMA treatment has emerged ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

The unprecedented incident yesterday at the EOPYY pharmacy on Alexandras Avenue has accelerated the implementation of ...